D. M. Fowler

High-resolution measurement of ERK activation state reveals determinants of BRAF regulation and drug sensitivity

High-resolution measurements of pathway activity make it possible to characterize how signaling responds to changing cellular conditions, to evaluate pathway-targeted inhibitors, and to dissect how sequence variation shapes signaling output. Here, we describe a sequencing-based assay that uses engineered, phospho-state...